A randomised phase II study of oxaliplatin alone versus oxaliplatin combined with 5-fluorouracil and folinic acid (Mayo Clinic regimen) in previously untreated metastatic colorectal cancer patientsAlberto Zori Comba, A. Schmilovich, Florencia Perazzo et al.|European Journal of Cancer|2001Cited by 37
Paclitaxel in platinum-resistant ovarian cancer patients. Argentine Multicenter Taxol Group.L. Ezcurdia, A.M. Alvarez, S Jovtis et al.|PubMed|1997Cited by 14
Phase II of doxorubicin/taxol in metastatic breast cancerClaudia Pazos, Albertoi Suárez, E. Mickiewicz et al.|Breast Cancer Research and Treatment|1999Cited by 10
Breast cancer care in Latin America and the Caribbean (LAC)Eduardo Cazap, Carlos Vallejos, Antônio C. Buzaid et al.|Journal of Clinical Oncology|2007Cited by 3
TAXOL® (paclitaxel) 1-hour infusion plus doxorubicin as first line treatment for metastatic breast cancer (MBC) patientsE. Mickiewicz, A.M. Alvarez, Masahiro Noto et al.|European Journal of Cancer|1997Cited by 0